Document is current

Any future updates will be listed below

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of alectinib and pembrolizumab for the adjuvant treatment of non-small cell lung cancer in Japan

Crossref DOI link: https://doi.org/10.1007/s10147-024-02620-1

Published Online: 2024-09-11

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark